Clinical trial Recruiting at 1 site Observational

Long COVID registry in Navarre

Official title: Persistent COVID-19 Registry in Navarre. (Persicov-19)

Run by Fundacion Miguel Servet · NCT07417176 · Data updated 2026-11-12

This project will collect health and symptom information from people in Navarre who had confirmed COVID-19 and still have symptoms after 3 months to see how common and what kinds of lasting problems they have.

Quick facts

Study typeObservational
SexAll
Enrollment200 (estimated)
SponsorFundacion Miguel Servet
Academic / other
Locations1 site (Pamplona, Navarre)
StatusRecruiting
StartedJanuary 4, 2021
Main results expectedMarch 1, 2026
Study endsMarch 31, 2026
Registry record updatedFebruary 20, 2026
Trial IDNCT07417176 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are people in Navarre with a laboratory-confirmed SARS-CoV-2 infection who continue to report new or worsening symptoms present more than three months after the acute infection.

Probably not a fit

People whose persistent symptoms clearly predated their COVID-19 infection or who cannot attend the single required in-person visit at the study site are unlikely to receive benefit from participation.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is an observational registry enrolling people with confirmed SARS-CoV-2 infection who report symptoms persisting more than three months. Investigators collect sociodemographic data (age, sex, ethnicity, smoking, comorbidities) and clinical/disease-management variables, including a checklist of persistent symptoms at a single visit. The goal is to determine the prevalence and medium- to long-term sequelae of COVID-19 in the Navarre population and to characterize patient subgroups. The registry is led by Fundación Miguel Servet and conducted at Hospital Universitario de Navarra in Pamplona.

Why it matters

Potential benefit: If successful, the registry could help clinicians and health planners better recognize common long COVID patterns and plan follow-up care and services for affected patients.

How similar studies have gone: Other hospital-based cohorts, such as the Carfi et al. cohort, have reported high rates of persistent symptoms after COVID-19, so this registry builds on existing observational findings rather than testing a novel therapy.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* History of confirmed SARS-CoV-2 infection
* Presentation of symptoms that have persisted for more than 3 months after SARS-CoV-2 infection
* The patient reports any of the symptoms listed in the clinical assessment questionnaire or checklist.

Exclusion Criteria:

* The symptom(s) referred to already existed prior to acute SARS-CoV-2 infection.

Where it's running

  • Hospital Universitario de Navarra
    Pamplona, Navarre, Spain
    Recruiting

Study contacts

  • Principal investigator: Patricia Fanlo Mateo, MD, PhD — Hospital Universitario de Navarra. Pamplona. Spain
  • Study coordinator: Ruth García Rey, SC
  • Email: ruth.garcia.rey@navarra.es
  • Phone: +3484822163

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.